Lombard Medical Technologies (LSE:LMT) Change In Receivables : £0.33 Mil (TTM As of Dec. 2012)

View and export this data going back to . Start your Free Trial

What is Lombard Medical Technologies Change In Receivables?

Lombard Medical Technologies's change in receivables for the quarter that ended in Dec. 2012 was £0.33 Mil. It means Lombard Medical Technologies's Accounts Receivable declined by £0.33 Mil from Dec. 2011 to Dec. 2012 .

Lombard Medical Technologies's change in receivables for the fiscal year that ended in Dec. 2012 was £0.33 Mil. It means Lombard Medical Technologies's Accounts Receivable declined by £0.33 Mil from Dec. 2011 to Dec. 2012 .

Lombard Medical Technologies's Accounts Receivable for the quarter that ended in Dec. 2012 was £0.90 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Lombard Medical Technologies's Days Sales Outstanding for the six months ended in Dec. 2012 was 42.04.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Lombard Medical Technologies's liquidation value for the six months ended in Dec. 2012 was £-0.69 Mil.

Lombard Medical Technologies Change In Receivables Historical Data

The historical data trend for Lombard Medical Technologies's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lombard Medical Technologies Change In Receivables Chart

Lombard Medical Technologies Annual Data

Trend

Sep02

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Change In Receivables

Get a 7-Day Free Trial

0.08

0.10

-0.35

-0.40

0.33

Lombard Medical Technologies Semi-Annual Data
	Sep02	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12
Change In Receivables	Get a 7-Day Free Trial					0.08	0.10	-0.35	-0.40	0.33

Lombard Medical Technologies Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2012 was £0.33 Mil.

Lombard Medical Technologies (LSE:LMT) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Lombard Medical Technologies's Days Sales Outstanding for the quarter that ended in Dec. 2012 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.896	/	3.89	*	91
=	42.04

2. In Ben Graham's calculation of liquidation value, Lombard Medical Technologies's accounts receivable are only considered to be worth 75% of book value:

Lombard Medical Technologies's liquidation value for the quarter that ended in Dec. 2012 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	2.748	-	5.086	+	0.75 * 0.896	+	0.5 * 1.96
=	-0.69

Lombard Medical Technologies Change In Receivables Related Terms

Thank you for viewing the detailed overview of Lombard Medical Technologies's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Lombard Medical Technologies (LSE:LMT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lombard Medical Technologies PLC (LSE:LMT) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.lombardmedical.com

Lombard Medical Technologies PLC is engaged in the design and development of endovascular stent grafts, their manufacture, and commercialization either directly through the group's own sales force or through a network of local distributors supported by clinical specialists from Lombard Medical. The principal product, the AorfixT AAA stent graft has European CE mark approval for use in patients with high-angle-neck aneurysms of up to 90 degrees. The group has operations in United Kingdom and United States of America.